​

Immunotherapy is a topic in the health domain with significant developments in policy, regulation, and public health impact.

Key developments include novartis and bristol myers pause autoimmune car-t trials due to safety concerns, fda approves trodelvy for first-line triple-negative breast cancer, innovent biologics doses first patient in phase 3 trial of ibi363 for advanced colorectal cancer, among other significant events and policy changes.

Source: Geo Health Space